<p>Omentum-derived MCs were treated or not with 1 ng/mL TGF-β1 for 12 or 24 hours, in the presence of different doses of Tamoxifen (0, 3 and 6 µM). <b>(A)</b> Quantitative RT-PCR demonstrates that Tamoxifen treatments prevent TGF-β1-induced E-cadherin mRNA down-regulation. <b>(B)</b> Quantitative RT-PCR shows that Tamoxifen blocks TGF-β1-mediated induction of Snail mRNA, the main transcriptional repressor of E-cadherin. The expression of E-cadherin mRNA was analyzed at 24 hours, whereas the expression of Snail mRNA was analyzed at 12 hours of treatments. Bars depict means ± SE of three independent experiments.</p
The original publication can be found at www.springerlink.comResponse to treatment with the antiestr...
Introduction: Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positiv...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
<p>Effluent-derived MCs with mesenchymal phenotype (as determined by non-epitheliod morphology, low ...
<p>Omentum-MCs were stimulated with TGF-β1 during 48 hours and then the cells were either left untre...
<p>Omentum-derived MCs were treated or not with 1 ng/mL TGF-β1 for 24 or 48 hours, in the presence o...
<p>Omentum-derived MCs were treated or not with 1 ng/mL TGF-β1 during 48 hours, in the presence of d...
Objective.: The transcription factor Snail, which is implicated in the triggering of epithelial-mese...
Summary Previously we have shown that tamoxifen (TAM) induces morphological and biochemical changes ...
Tamoxifen (TAM) exerts a long-term suppressive effect on human breast cancer cell proliferation on. ...
The objective of this study was to investigate the effect of Tamoxifen (TAM) treatment on epidermal ...
Tamoxifen was proven to reduce the incidence of breast cancer by 49% in women at increased risk of t...
<p>Western blot analysis of the expression levels of ER-α66, ER-α36, HER2 and EGFR in ER-positive br...
Objectives: To examine the effects of triiodothyronine (T3), 17β-estradiol (E2), and tamoxifen (TAM)...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
The original publication can be found at www.springerlink.comResponse to treatment with the antiestr...
Introduction: Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positiv...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
<p>Effluent-derived MCs with mesenchymal phenotype (as determined by non-epitheliod morphology, low ...
<p>Omentum-MCs were stimulated with TGF-β1 during 48 hours and then the cells were either left untre...
<p>Omentum-derived MCs were treated or not with 1 ng/mL TGF-β1 for 24 or 48 hours, in the presence o...
<p>Omentum-derived MCs were treated or not with 1 ng/mL TGF-β1 during 48 hours, in the presence of d...
Objective.: The transcription factor Snail, which is implicated in the triggering of epithelial-mese...
Summary Previously we have shown that tamoxifen (TAM) induces morphological and biochemical changes ...
Tamoxifen (TAM) exerts a long-term suppressive effect on human breast cancer cell proliferation on. ...
The objective of this study was to investigate the effect of Tamoxifen (TAM) treatment on epidermal ...
Tamoxifen was proven to reduce the incidence of breast cancer by 49% in women at increased risk of t...
<p>Western blot analysis of the expression levels of ER-α66, ER-α36, HER2 and EGFR in ER-positive br...
Objectives: To examine the effects of triiodothyronine (T3), 17β-estradiol (E2), and tamoxifen (TAM)...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
The original publication can be found at www.springerlink.comResponse to treatment with the antiestr...
Introduction: Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positiv...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...